Synthesis of 2,3-trans-3,4-trans-2-aryl-3-alkyl/aryl chroman-4-ols

Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry

Volumn 44, Issue 3, 2005, Pages 618-621

  Venkati, M ^a   Krupadanam, G L David ^a  

^a OSMANIA UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

4 CHROMANONE DERIVATIVE; 4 METHOXY 2 HYDROXYBUTYROPHENONE; 4 METHOXY 2 HYDROXYDESOXYBENZOIN; 4 METHOXY 2 HYDROXYPROPIOPHENONE; 7 METHOXY 2,3 DIPHENYLCHROMAN 4 OL; 7 METHOXY 2,3 DIPHENYLCHROMAN 4 ONE; 7 METHOXY 3 ETHYL 2 (4 METHOXYPHENYL)CHROMAN 4 OL; 7 METHOXY 3 ETHYL 2 (4 METHOXYPHENYL)CHROMAN 4 ONE; 7 METHOXY 3 METHYL 2 (4 METHYLPHENYL)CHROMAN 4 OL; 7 METHOXY 3 METHYL 2 (4 METHYLPHENYL)CHROMAN 4 ONE; ACID; ALDEHYDE DERIVATIVE; ALKALI; ALKYL GROUP; BORATE SODIUM; CHALCONE DERIVATIVE; CHROMAN 4 OL DERIVATIVE; CHROMAN DERIVATIVE; NATURAL PRODUCT; PAROXYPROPIONE; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CATALYSIS; CHIRALITY; CIS ISOMER; CYCLIZATION; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; EPIMERIZATION; INFRARED SPECTROSCOPY; KNOEVENAGEL CONDENSATION; MASS SPECTROMETRY; PROTON NUCLEAR MAGNETIC RESONANCE; REDUCTION; STEREOISOMERISM; STRUCTURE ANALYSIS; TECHNIQUE; TRANS ISOMER; ULTRAVIOLET SPECTROSCOPY;

EID: 17444373106     PISSN: 03764699     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Lipinski A C, Aldinger E C, Beyer A T, Bordner J, Burdi F D, Bussolotti L B, Inskeep B P & Siegel W T, J Med Chem, 35, 1992, 2169.
2. Ares J J, Outt E P, Randall L J, Murray D P, Weisshaav S P, Beien M L, EMS L B, Kakodkar V S, Kelm R G, Kershaw C W, Werchowski M K & Parkinson A, J Med Chem, 38, 1995, 4937.
3. Hayashi K & Hyashi T, Antiviral Chem Chemother, 7, 1996, 79.
4. Atwal S K, Grover J G, Ahmed Z S, Ferrara N F, Harper W T, Kim S, Sleph G R, Dzwonczyk S, Russell D A, Moreland S, Mecullough R J & Normandin E D, J Med Chem. 36, 1993, 3971.
5. Sagramora P D, Mancini U, Valanti P & Cima L, J Med Chem, 13, 1970, 527
6. Setnikar I, Cova A & Magistretti M, J Arzneimittel-Forsch, 25, 1975, 1916.
7. Boyd M R, Cardellina J H, Gustafson K R, McMahon J B, Fuller R W, Cragg G M & Kashman Y, Calanolide antiviral cpds, compsns. and uses thereof (Dept Health & Human Services, Univ Illinois), EP 633887, JP 96502948, JP96507311, WO 9320082, WO 9428000, US 5591770.
8. Kashman Y, Gustafson K R, Fuller R W, Cardellina J H, McMahon J B, Currens M J, Buckheit R W Jr, Hughes S H, Cragg G M & Boyd M R, J Med Chem, 35, 1992, 2735
9. Gsuthier S, Caron B, Cloutier J, Dory Y L, Favre A, Larouche D, Mailhot J, Ouellet C, Schwerdtfeger A, Leblanc G, Martel C, Simard J, Merand Y, Belanger A, Labrie C & Labrie F, J Med Chem, 40, 1997, 2117
10. Verma B S, Dhindsa K S & Sangwan N K, Indian J Chem, 32B, 1993, 239.
11. Kamboj V P, Ray S & Dhawan B N, Drugs Today, 28, 1992, 227
12. Saeed A, Sharma A P, Durani N, Jain R, Durani S & Kapil R S, J Med Chem, 33, 1990, 3210.
13. Janzso G, Kallay F & Koczar I, Tetrahedron, 28, 1972, 2545.
14. Hisao K, Shigeru N, Naoko Y, Akira O, Fumio S, Hiroyuki S, Mansanori O & Nobuo T, J Antibiotics, 12, 1990, 1533.
15. Draper R W, Radha B H, Iyer V, XunLi YuelieLu, Mohammad Rahman & Vater E J, Tetrahedron, 56, 2000, 1811
16. Venkati M & David Krupadanam G L, Synth Comm, 31, 2001, 2589.
17. Venkati M & David Krupadanam G L, Synth Comm, 32, 2002, 2227